Vybrique is the first FDA-approved sildenafil oral film for the treatment of erectile dysfunction in adult men. The new prescription product contains the same established PDE5 inhibitor associated with Viagra, but delivers it in a thin film that disintegrates on the tongue and can be swallowed with saliva without water.
The FDA approved Vybrique in December 2025, and IBSA USA announced the approval in February 2026. The arrival of this formulation is noteworthy because sildenafil treatment for erectile dysfunction in the United States had centered on conventional oral tablets. Vybrique introduces a distinctly different way to take the medicine while preserving the familiar sildenafil dose range.
For patients and clinicians following new erectile dysfunction treatments in 2026, Vybrique is less about a new active ingredient and more about a new delivery format. Its main innovation is the FDA-reviewed oral film itself.
Why the FDA Approval of Vybrique Is Significant
Sildenafil has been used for erectile dysfunction since the FDA approved Viagra in 1998. Over time, generic tablets made the active ingredient widely available, but the basic administration method changed very little. Vybrique expands the category with a single-dose film designed to dissolve directly on the tongue.
This makes the Vybrique FDA approval an important formulation milestone. At the time of approval, the manufacturer described it as the first and only FDA-approved oral sildenafil film for erectile dysfunction in the United States. The product is intended for men aged 18 years and older and remains available only by prescription.
What Is Vybrique Sildenafil Oral Film?
Vybrique contains sildenafil citrate in an amount equivalent to 25 mg, 50 mg, 75 mg or 100 mg of sildenafil. Each dose is supplied as an opaque light blue, thin and flexible film with a lemon and grapefruit scent. The film carries a strength-specific imprint and is sealed in an individual foil pouch.
The film is placed directly on the tongue, where it disintegrates before being swallowed with saliva. It does not need to be taken with water. The label specifically states that the film should not be cut or chewed, which is important because each pouch contains a complete single dose.
Vybrique cartons contain four or eight individually packaged films. The separate pouches protect each dose and make the product easier to carry without removing it from its original packaging.
How Vybrique Differs From Viagra and Sildenafil Tablets
Vybrique, Viagra and generic sildenafil ED tablets share the same active drug. Sildenafil inhibits phosphodiesterase type 5, commonly called PDE5, and supports increased blood flow to the penis during sexual stimulation. None of these products causes an automatic erection or increases sexual desire.
The meaningful difference is the dosage form. Viagra and most generic sildenafil products are solid tablets swallowed by mouth. Vybrique sildenafil oral film disintegrates on the tongue and can be taken without water. This may appeal to patients who dislike swallowing tablets, have difficulty doing so or prefer a more portable single-dose format.
The film should not automatically be described as faster or stronger than a tablet. Clinical research on sildenafil oral films has focused on bioequivalence and administration convenience. Studies of IBSA sildenafil films found systemic exposure comparable to conventional sildenafil tablets under the tested conditions. Individual onset can still vary with dose, food, health conditions and other medicines.
Four Strengths Include a New 75 mg Sildenafil Option
Vybrique is available in 25 mg, 50 mg, 75 mg and 100 mg films. The inclusion of a 75 mg film is distinctive because the familiar Viagra tablet range generally includes 25 mg, 50 mg and 100 mg strengths.
- 25 mg is the lower film strength and may be selected when reduced sildenafil exposure is appropriate.
- 50 mg is the labeled starting dose for most patients.
- 75 mg provides an intermediate step between the usual 50 mg and 100 mg options.
- 100 mg is the maximum recommended single dose.
The presence of four strength options does not mean that patients should choose a dose on their own. Age, previous response, tolerability, liver or kidney impairment, interacting medicines and cardiovascular health can all affect the dose selected by a prescriber.
How and When the New Oral Film Is Taken
For most patients, the recommended Vybrique dose is 50 mg taken as needed approximately one hour before sexual activity. According to the prescribing information, it may be taken from 30 minutes to four hours before sexual activity. The maximum recommended frequency is once per day.
To use the product, the patient opens one pouch and places the entire film on the tongue. The film is allowed to disintegrate and is then swallowed with saliva. It may be taken with or without food, and no water or other liquid is required.
The labeled instructions are specific to the finished Vybrique product. Patients should not cut the film, chew it, combine multiple lower-strength films without medical direction or substitute an unapproved product marketed as a sildenafil strip.
Who May Find the Oral Film Format Useful?
The new format may be relevant for adults who have difficulty swallowing tablets or who prefer medication that does not require water at the time of use. Individually sealed films may also be more convenient to carry than a bottle of tablets.
These practical features do not make Vybrique appropriate for every patient. The prescribing decision still depends on whether sildenafil is safe for the individual, whether sexual activity is medically advisable and whether the film’s inactive ingredients are suitable.
What the New Formulation Does Not Change
Although the dosage form is new, the main sildenafil precautions remain. Vybrique is a prescription medicine, and it should not be combined with Viagra, generic sildenafil or another PDE5 inhibitor. It does not prevent sexually transmitted infections and is not approved for women or children.
The product also does not eliminate the need to investigate erectile dysfunction. ED can be associated with cardiovascular disease, diabetes, medication effects, hormonal conditions, neurologic disease, psychological factors or a combination of causes. A new formulation can make treatment more convenient, but it does not replace an appropriate medical assessment.
Nitrates and Other Important Vybrique Interactions
Vybrique must not be used with nitrates or nitric oxide donors because sildenafil can intensify their blood-pressure-lowering effect. It is also contraindicated with guanylate cyclase stimulators such as riociguat. These combinations can cause a sudden and dangerous drop in blood pressure.
A clinician should review alpha-blockers, blood-pressure medicines, ritonavir, strong CYP3A inhibitors and other erectile dysfunction treatments before prescribing the film. A lower starting dose may be required for adults older than 65, patients with severe kidney impairment, patients with liver impairment and those taking certain interacting medicines.
Side Effects and Symptoms That Require Urgent Care
Common sildenafil adverse effects include headache, flushing, indigestion, nasal congestion, dizziness, nausea, back pain, muscle pain, rash and temporary visual changes. The likelihood and intensity of these effects can vary with the prescribed dose and individual health factors.
Call 911 for chest pain, fainting, severe breathing difficulty or another rapidly worsening reaction. Immediate medical evaluation is also required for an erection lasting longer than four hours, sudden vision loss, sudden hearing loss or signs of a severe allergic reaction.
When Will Vybrique Become Available?
Vybrique is a recently approved brand, so availability may develop gradually as pharmacies and health plans add the new oral film to their systems. Sweetwater Medical Center will update its medication information when Vybrique becomes available through the applicable pharmacy-order pathway.
Until then, patients should be cautious with websites using the Vybrique name for products that cannot be matched to FDA-approved labeling. The authentic product is supplied in individual pouches with a strength-specific film imprint and an NDC associated with IBSA Pharma Inc.
What Vybrique May Change in Erectile Dysfunction Treatment
The most important change is choice. Some patients are comfortable with tablets, while others may prefer a film that is placed on the tongue and taken without water. Vybrique adds an FDA-approved option for the second group without introducing an unfamiliar active ingredient.
Its long-term place in treatment will depend on patient preference, prescriber experience, availability, insurance coverage and how the new formulation performs in routine clinical use. For now, the approval represents a notable expansion of sildenafil dosage forms in the United States.
Medical Disclaimer
This article provides general news and medical information about Vybrique and sildenafil oral film. It does not replace an individual diagnosis, cardiovascular assessment, prescription or treatment plan.
Do not start sildenafil, change the prescribed dose or combine erectile dysfunction medicines without guidance from a qualified healthcare professional.
Related Sildenafil and Erectile Dysfunction Information
Medical References
Pharmacist Review of Vybrique Medication Information
The medication information in this article, including Vybrique product identity, FDA-approved indication, oral-film administration, available strengths, sildenafil interactions, adverse effects and urgent warnings, was reviewed by Veronica K. Donaldson, PharmD, Pharmacist, Wyoming Pharmacist License 2669; NPI 1003968520.
This review applies to the general information published in the article and does not approve an individual prescription or treatment decision.
Last pharmacist review: 08.21.2026.